Novo Nordisk A/S & Eli Lilly and Company cut prices for top diabetes drugs, boosting accessibility and potential revenue.
Health Affairs' Jeff Byers welcomes Rachel Sachs from Washington University in St. Louis and Deputy Editor Chris Fleming back ...
The people dancing and singing in pharmaceutical commercials brag that “Drug X lowered my A1C!” This seems to make them happy ...
Leaders at the Department of Health and Human Services (HHS) are bullish on artificial intelligence to help patients manage ...
Data is the driving force behind modern marketing. Every click, every impression, every conversion teaches a brand something ...
The Schumer Shutdown may soon end, but we might have avoided it entirely had the Medicaid discussion been transparent.
As open enrollment rolls on, thousands of Rhode Islanders will have the option to select plans for Medicare. Here’s a guide on how to choose wisely.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback